If we traded just Procter & Gamble and Bristol Myers at Cramer Berkowitz, we could know them inside out. But we wouldn't make much, let alone beat the averages. All the action in this year's market has been in stocks of the moment, those newly minted dotcoms or dotcom-related issues that seem to soar 30 and 40 points at a clip. There's only one problem with owning them. Call us old-fashioned, but we like to know more about stocks than their symbols and past trajectories.
We like to know what the companies behind them do, what areas they are trying to...
To continue reading:
or
Log-In
